Novo CEO pressed by Senate to cut rates of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would contemplate new talks with insurers with regard to the list charges of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. Elevance https://aya-healthcare-address00001.blogscribble.com/30716397/everything-about-healthcare-news